The GLP-1 Revolution: How Next-Generation Obesity Drugs Are Reshaping Global Healthcare Obesity now affects more than 1 billion people globally, making it one of the most urgent public health and pharmaceutical market opportunities of this decade
2027 Capturing the impact of Facioscapulohumeral Muscular Dystrophy (FSHD) on Health-related Quality of Life (HRQoL): a systematic review of the reliability and validity of existing self-report instruments using COSMIN Jill Carlton 1 , Philip Powell 1 , S Frances 1 , Claire Williams 1 , Anthea Sutton 1 , Jonathan Street 1 , Channa Hewamadduma 1 , Jill Carlton 1 1 University of Sheffield, Sheffield, UK Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :2027 Aims Facioscapulohumeral muscular dystrophy (FSHD) is a rare genetic muscle wasting condition causing progressive weakness
It has been shown that carnitine has a significant dose-dependent effect in promoting random pattern skin flap survival [104]
Mean annual out-of-pocket payments decreased in nominal dollars, dropping from $414 to $252 for patients with diabetes and from $212 to $157 for those without
What makes medical weight loss with Semaglutide more effective than traditional methods
